NCT06222788View on ClinicalTrials.gov

Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)

NANot yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Breast Cancer

Interventions

DEVICE

Convertible Plasma Jet

NTP will be applied to the patients using the Convertible Plasma Jet (CPJ, NexPlasmaGen Inc.)

Trial Locations (1)

h2X0A9

Centre Hospitalier de l'Université de Montréal - CHUM, Montreal

Sponsors

Collaborators (1)

Ozmosis Research Inc.

All Listed Sponsors

collaborator

Ozmosis Research Inc.

INDUSTRY

collaborator

Ministère de l'Économie, de l'Innovation et de l'Énergie, Québec, Canada

UNKNOWN

collaborator

Quebec Breast Cancer Foundation

OTHER

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER